[Inhaled bronchodilators and mucolytic agents in cystic fibrosis].
Identifieur interne : 000E19 ( France/Analysis ); précédent : 000E18; suivant : 000E20[Inhaled bronchodilators and mucolytic agents in cystic fibrosis].
Auteurs : P. Le Roux [France] ; B. Le LuyerSource :
- Archives de pediatrie : organe officiel de la Societe francaise de pediatrie [ 0929-693X ] ; 2003.
English descriptors
- KwdEn :
- MESH :
- chemical , therapeutic use : Bronchodilator Agents, Deoxyribonucleases, Expectorants, Recombinant Proteins.
- drug therapy : Cystic Fibrosis.
- Administration, Inhalation, Humans.
Abstract
Poor clearance of airway secretions contributes to the pulmonary disease in cystic fibrosis (CF). Bronchodilator therapy might benefit in CF, but the efficacy is controversial. Effects of mucolytic agents have not been demonstrated conclusively. Only, efficacy of recombinant human deoxyribonuclease (rhDNase) is established with a rapid onset of benefit.
PubMed: 14671935
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: 000338
- to stream PubMed, to step Curation: 000338
- to stream PubMed, to step Checkpoint: 000338
- to stream Ncbi, to step Merge: 000089
- to stream Ncbi, to step Curation: 000089
- to stream Ncbi, to step Checkpoint: 000089
- to stream Main, to step Merge: 001477
- to stream Main, to step Curation: 001443
- to stream Main, to step Exploration: 001443
- to stream France, to step Extraction: 000E19
Links to Exploration step
pubmed:14671935Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">[Inhaled bronchodilators and mucolytic agents in cystic fibrosis].</title><author><name sortKey="Le Roux, P" sort="Le Roux, P" uniqKey="Le Roux P" first="P" last="Le Roux">P. Le Roux</name><affiliation wicri:level="3"><nlm:affiliation>Centre de ressources et de compétence dans la mucoviscidose, département de pédiatrie, groupe hospitalier, 55 bis, rue Gustave-Flaubert, 76600 Le Havre, France. pleroux@ch-havre.fr</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Centre de ressources et de compétence dans la mucoviscidose, département de pédiatrie, groupe hospitalier, 55 bis, rue Gustave-Flaubert, 76600 Le Havre</wicri:regionArea><placeName><region type="region" nuts="2">Région Normandie</region><region type="old region" nuts="2">Haute-Normandie</region><settlement type="city">Le Havre</settlement></placeName></affiliation></author><author><name sortKey="Le Luyer, B" sort="Le Luyer, B" uniqKey="Le Luyer B" first="B" last="Le Luyer">B. Le Luyer</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2003">2003</date><idno type="RBID">pubmed:14671935</idno><idno type="pmid">14671935</idno><idno type="wicri:Area/PubMed/Corpus">000338</idno><idno type="wicri:Area/PubMed/Curation">000338</idno><idno type="wicri:Area/PubMed/Checkpoint">000338</idno><idno type="wicri:Area/Ncbi/Merge">000089</idno><idno type="wicri:Area/Ncbi/Curation">000089</idno><idno type="wicri:Area/Ncbi/Checkpoint">000089</idno><idno type="wicri:doubleKey">0929-693X:2003:Le Roux P:inhaled:bronchodilators:and</idno><idno type="wicri:Area/Main/Merge">001477</idno><idno type="wicri:Area/Main/Curation">001443</idno><idno type="wicri:Area/Main/Exploration">001443</idno><idno type="wicri:Area/France/Extraction">000E19</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">[Inhaled bronchodilators and mucolytic agents in cystic fibrosis].</title><author><name sortKey="Le Roux, P" sort="Le Roux, P" uniqKey="Le Roux P" first="P" last="Le Roux">P. Le Roux</name><affiliation wicri:level="3"><nlm:affiliation>Centre de ressources et de compétence dans la mucoviscidose, département de pédiatrie, groupe hospitalier, 55 bis, rue Gustave-Flaubert, 76600 Le Havre, France. pleroux@ch-havre.fr</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Centre de ressources et de compétence dans la mucoviscidose, département de pédiatrie, groupe hospitalier, 55 bis, rue Gustave-Flaubert, 76600 Le Havre</wicri:regionArea><placeName><region type="region" nuts="2">Région Normandie</region><region type="old region" nuts="2">Haute-Normandie</region><settlement type="city">Le Havre</settlement></placeName></affiliation></author><author><name sortKey="Le Luyer, B" sort="Le Luyer, B" uniqKey="Le Luyer B" first="B" last="Le Luyer">B. Le Luyer</name></author></analytic><series><title level="j">Archives de pediatrie : organe officiel de la Societe francaise de pediatrie</title><idno type="ISSN">0929-693X</idno><imprint><date when="2003" type="published">2003</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Administration, Inhalation</term><term>Bronchodilator Agents (therapeutic use)</term><term>Cystic Fibrosis (drug therapy)</term><term>Deoxyribonucleases (therapeutic use)</term><term>Expectorants (therapeutic use)</term><term>Humans</term><term>Recombinant Proteins (therapeutic use)</term></keywords><keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Bronchodilator Agents</term><term>Deoxyribonucleases</term><term>Expectorants</term><term>Recombinant Proteins</term></keywords><keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Cystic Fibrosis</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Administration, Inhalation</term><term>Humans</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Poor clearance of airway secretions contributes to the pulmonary disease in cystic fibrosis (CF). Bronchodilator therapy might benefit in CF, but the efficacy is controversial. Effects of mucolytic agents have not been demonstrated conclusively. Only, efficacy of recombinant human deoxyribonuclease (rhDNase) is established with a rapid onset of benefit.</div></front></TEI><affiliations><list><country><li>France</li></country><region><li>Haute-Normandie</li><li>Région Normandie</li></region><settlement><li>Le Havre</li></settlement></list><tree><noCountry><name sortKey="Le Luyer, B" sort="Le Luyer, B" uniqKey="Le Luyer B" first="B" last="Le Luyer">B. Le Luyer</name></noCountry><country name="France"><region name="Région Normandie"><name sortKey="Le Roux, P" sort="Le Roux, P" uniqKey="Le Roux P" first="P" last="Le Roux">P. Le Roux</name></region></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/France/explor/LeHavreV1/Data/France/Analysis
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000E19 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/France/Analysis/biblio.hfd -nk 000E19 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/France
|area= LeHavreV1
|flux= France
|étape= Analysis
|type= RBID
|clé= pubmed:14671935
|texte= [Inhaled bronchodilators and mucolytic agents in cystic fibrosis].
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/France/Analysis/RBID.i -Sk "pubmed:14671935" \
| HfdSelect -Kh $EXPLOR_AREA/Data/France/Analysis/biblio.hfd \
| NlmPubMed2Wicri -a LeHavreV1
| This area was generated with Dilib version V0.6.25. |  |